Bryan G. Belikoff, Ph.D.
Affiliations: | 2012 | Boston University, Boston, MA, United States |
Area:
Immunology, PharmacologyGoogle:
"Bryan Belikoff"Parents
Sign in to add mentor| Daniel G. Remick | grad student | 2012 | Boston University | |
| (Regulation of the immunosuppressive hypoxia-A2 adenosinergic pathway: A potential therapeutic target for the treatment of bacterial sepsis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Belikoff BG, Vaickus LJ, Sitkovsky M, et al. (2024) Corrections: A2B adenosine receptor expression by myeloid cells is pro-inflammatory in murine allergic-airway inflammation. Journal of Immunology (Baltimore, Md. : 1950) |
| Georgiev P, Belikoff BG, Hatfield S, et al. (2013) Genetic deletion of the HIF-1α isoform I.1 in T cells enhances antibacterial immunity and improves survival in a murine peritonitis model. European Journal of Immunology. 43: 655-66 |
| Belikoff BG, Vaickus LJ, Sitkovsky M, et al. (2012) A2B adenosine receptor expression by myeloid cells is proinflammatory in murine allergic-airway inflammation. Journal of Immunology (Baltimore, Md. : 1950). 189: 3707-13 |
| Moitra R, Beal DR, Belikoff BG, et al. (2012) Presence of preexisting antibodies mediates survival in sepsis. Shock (Augusta, Ga.). 37: 56-62 |
| Belikoff BG, Hatfield S, Georgiev P, et al. (2011) A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice. Journal of Immunology (Baltimore, Md. : 1950). 186: 2444-53 |
| Belikoff B, Hatfield S, Sitkovsky M, et al. (2011) Adenosine negative feedback on A2A adenosine receptors mediates hyporesponsiveness in chronically septic mice. Shock (Augusta, Ga.). 35: 382-7 |
| Hatfield S, Belikoff B, Lukashev D, et al. (2009) The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells. Journal of Leukocyte Biology. 86: 545-8 |
| Buras JA, Holt D, Orlow D, et al. (2006) Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Critical Care Medicine. 34: 2624-9 |
| Yano K, Liaw PC, Mullington JM, et al. (2006) Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. The Journal of Experimental Medicine. 203: 1447-58 |